Finance

Lists
Why is VIR down 3,44%?
Dive Deeper
VIR:NASDAQ
Vir Biotechnology Inc
9,25 USD
-3,44%
(-0,33) 1D
9,25 USD
0,00% (0,00)
After hours
Closed: 17-ноя., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VIR...
Open
9,58 USD
High
9,75 USD
Low
9,03 USD
Mkt. cap
1,58 млд
Avg. vol.
2,67 млн
Volume
2,83 млн
52-wk high
14,38 USD
52-wk low
5,32 USD
EPS
-1,26 USD
Beta
1,70
Shares outstanding
171,27 млн
No. of employees
367
Open
9,58 USD
High
9,75 USD
Low
9,03 USD
Mkt. cap
1,58 млд
Avg. vol.
2,67 млн
Volume
2,83 млн
52-wk high
14,38 USD
52-wk low
5,32 USD
EPS
-1,26 USD
Beta
1,70
Shares outstanding
171,27 млн
No. of employees
367
News stories
From web sources and news partners
About Vir Biotechnology Inc
CEOMarianne De Backer
Employees367
Founded2016-ж., 7-апр.
HeadquartersСан Франциско, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitevir.bio
Analyst ratings
Based on 8 analysts giving stock ratings to VIR in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for VIR in the last 3 months.
Highest
Current 9,25 USD
30,00 USD (+224,32%)
Average
22,43 USD (+142,49%)
Lowest
17,00 USD (+83,78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Etzer Darout
Barclays
Buy
Maintained
30,00 USD
+224,3%
11/11/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
25,00 USD
+170,3%
11/10/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
28,00 USD
+202,7%
11/10/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
22,00 USD
+137,8%
11/10/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
17,00 USD
+83,8%
11/06/2026
Roanna Ruiz
Leerink Partners
Buy
Reiterated
17,00 USD
+83,8%
11/05/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
11/05/2026
Joseph Stringer
Needham
Buy
Maintained
18,00 USD
+94,6%
09/28/2026
Paul Choi
Goldman Sachs
Buy
Maintained
21,00 USD
+127%
05/06/2026
Sean McCutcheon
Raymond James
Buy
Maintained
19,00 USD
+105,4%
02/24/2026
Last report
2026-ж., 4-ноя.
Fiscal period
Q3 2026
-0,57 USD / -0,75 USD
+23,51%beat
Revenue / Est. (USD)
-188,00 миң / 1,38 млн
-113,62%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
64,07 млн
-29,00 миң
238,95 млн
-188,00 миң
Cost of goods sold
88,46 млн
109,81 млн
135,28 млн
80,04 млн
Cost of revenue
88,46 млн
109,81 млн
135,28 млн
80,04 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23,62 млн
23,34 млн
30,20 млн
24,43 млн
Operating expense
23,62 млн
23,34 млн
30,20 млн
24,43 млн
Total operating expenses
112,07 млн
133,15 млн
165,48 млн
104,47 млн
Operating income
-48,00 млн
-133,18 млн
73,47 млн
-104,66 млн
Other non operating income
-335,00 миң
-254,00 миң
-451,00 миң
-651,00 миң
EBT including unusual items
-43,06 млн
-125,52 млн
80,26 млн
-96,40 млн
EBT excluding unusual items
-40,53 млн
-126,24 млн
81,98 млн
-95,99 млн
Income tax expense
-137,00 миң
170,00 миң
179,00 миң
-143,00 миң
Effective tax rate
0,32%
-0,14%
0,22%
0,15%
Other operating expenses
-
-
-
-
Net income
-42,92 млн
-125,70 млн
80,08 млн
-96,25 млн
Net profit margin
-66,99%
433 431,03%
33,51%
51 197,87%
Earnings per share
-0,31
-0,85
0,47
-0,57
Interest and investment income
7,80 млн
7,19 млн
8,97 млн
9,32 млн
Interest expense
-
-
-
-
Net interest expenses
7,80 млн
7,19 млн
8,97 млн
9,32 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-45,10 млн
-130,37 млн
76,27 млн
-101,89 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору